相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Therapy Response Assessment in Metastatic Melanoma Patients Treated with a BRAF Inhibitor: Adapted Choi Criteria Can Reflect Early Therapy Response Better than Does RECIST
Monika Uhrig et al.
ACADEMIC RADIOLOGY (2013)
Tumor Heterogeneity and Permeability as Measured on the CT Component of PET/CT Predict Survival in Patients with Non-Small Cell Lung Cancer
Thida Win et al.
CLINICAL CANCER RESEARCH (2013)
Assessment of Primary Colorectal Cancer Heterogeneity by Using Whole-Tumor Texture Analysis: Contrast-enhanced CT Texture as a Biomarker of 5-year Survival
Francesca Ng et al.
RADIOLOGY (2013)
Quantitative Imaging in Cancer Evolution and Ecology
Robert A. Gatenby et al.
RADIOLOGY (2013)
Non-Small Cell Lung Cancer: Histopathologic Correlates for Texture Parameters at CT
Balaji Ganeshan et al.
RADIOLOGY (2013)
Monitoring targeted therapy using dual-energy CT: semi-automatic RECIST plus supplementary functional information by quantifying iodine uptake of melanoma metastases
M. Uhrig et al.
CANCER IMAGING (2013)
Contrast-Enhanced Dual-Energy CT of Gastrointestinal Stromal Tumors Is Iodine-Related Attenuation a Potential Indicator of Tumor Response?
Paul Apfaltrer et al.
INVESTIGATIVE RADIOLOGY (2012)
Intratumoral Molecular Heterogeneity in a BRAF-Mutant, BRAF Inhibitor-Resistant Melanoma: A Case Illustrating the Challenges for Personalized Medicine
James S. Wilmott et al.
MOLECULAR CANCER THERAPEUTICS (2012)
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Fei Su et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Dual Energy CT for Monitoring Targeted Therapies in Patients with Advanced Gastrointestinal Stromal Tumor: Initial Results
N. Schramm et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Vemurafenib
Keith. T. Flaherty et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Novel Oncologic Drugs: What They Do and How They Affect Images
Roberto Garcia Figueiras et al.
RADIOGRAPHICS (2011)
Assessment of Response to Tyrosine Kinase Inhibitors in Metastatic Renal Cell Cancer: CT Texture as a Predictive Biomarker
Vicky Goh et al.
RADIOLOGY (2011)
Tumor Response Evaluation in Oncology: Current Update
Alampady Krishna Prasad Shanbhogue et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2010)
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag et al.
NATURE (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Texture analysis in non-contrast enhanced CT: Impact of malignancy on texture in apparently disease-free areas of the liver
Balaji Ganeshan et al.
EUROPEAN JOURNAL OF RADIOLOGY (2009)
Dual energy CT: preliminary observations and potential clinical applications in the abdomen
Anno Graser et al.
EUROPEAN RADIOLOGY (2009)
Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell Proliferation
Bin Zheng et al.
MOLECULAR CELL (2009)
Uncoupling of the LKB1-AMPKα Energy Sensor Pathway by Growth Factors and Oncogenic BRAFV600E
Rosaura Esteve-Puig et al.
PLOS ONE (2009)
Dual-Energy CT in Patients Suspected of Having Renal Masses: Can Virtual Nonenhanced Images Replace True Nonenhanced Images?
Anno Graser et al.
RADIOLOGY (2009)
Colorectal Cancer: Texture Analysis of Portal Phase Hepatic CT Images as a Potential Marker of Survival
Kenneth A. Miles et al.
RADIOLOGY (2009)
Technical principles of dual source CT
Martin Petersilka et al.
EUROPEAN JOURNAL OF RADIOLOGY (2008)
Response evaluation of gastrointestinal stromal tumors
Haesun Choi
ONCOLOGIST (2008)
Material differentiation by dual energy CT: initial experience
Thorsten R. C. Johnson et al.
EUROPEAN RADIOLOGY (2007)
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria
Haesun Choi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Monitoring chemotherapy and radiotherapy of solid tumors
Wolfgang A. Weber et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: Initial clinical results
AR Padhani et al.
RADIOLOGY (2006)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI
YC Chang et al.
PHYSICS IN MEDICINE AND BIOLOGY (2004)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)